PolyPid Ltd (NAS:PYPD)

Q1 2026 PolyPid Ltd Earnings Call Transcript

May 13, 2026 / 12:30 PM GMT

Release Date Price: $4.22 (-7.46%)

Transcript

Key Points

Positve

PolyPid Ltd (PYPD) has initiated the NDA submission for DPLEX-100 to the FDA, with the expectation of completing it imminently.
The company received a small business waiver from the FDA for the PDUFA fee, saving approximately $4.3 million.
Strategic partnership discussions in the U.S. are in late stages, focusing on definitive agreement terms.
PolyPid Ltd (PYPD) has conducted multiple mock inspections to prepare for FDA inspection, with no major issues identified.
The company has fully repaid its outstanding debt obligations, strengthening its balance sheet ahead of potential commercialization.

Negative

PolyPid Ltd (PYPD) reported a net loss of $7.7 million for Q1 2026, although this is an improvement from the previous year.
General and administrative expenses increased to $1.6 million from $1.2 million in the same period last year.
The company's cash reserves decreased from $12.9 million to $10.9 million as of March 31, 2026.
There is uncertainty regarding the timeline for FDA inspection due to potential geopolitical issues in the Middle East.
The company anticipates some increase in operational expenses as commercialization efforts expand.

Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

PYPD.OQ - PolyPid Ltd
Q1 2026 PolyPid Ltd Earnings Call
May 13, 2026 / 12:30PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Greetings and welcome to Polypede's first quarter 2026 earnings conference call.

At this time, participants are in a listen-only mode. As a reminder, this call is recorded and I would now like to introduce your host for today's conference, Yehuda Libra from Ark's Investor Relations. Mr. Libra, you may begin.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Thank you, operator, and thank you all for joining Polypid's First Quarter 2026 Earnings Conference Call. Joining me on the call today will be Diklar Chachkis Axelabrad, Chief Executive Officer of Polypid, Johnny Misalawin, Polypid's

Already have an account? Log in

Get the full story

Subscribe Now

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Calculators Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App Newsletters Signup 中文

Education

Financial Glossary Tutorials FAQ Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.